In this Issue
New data and their potential effect on how you evaluate your patients.
CHIEF MEDICAL EDITOR'S PAGE
By Ted E. Feldman, MD, FSCAI - Chief Medical Editor
Gregg W. Stone, MD, discusses the success of TCT 2009, delves into the promise of TAVI, and provides a wrap-up of some of the important breaking trials you might have missed.
By Gregg W. Stone, MD
Integrating trial results into the current management of left main coronary disease.
By Ted Feldman, MD, FESC, FACC, FSCAI, and Issam D. Moussa, MD, FACC, FSCAI
A step-by-step guide on how to calculate the SYNTAX score, including how to access the program and screen shots from the SYNTAX Web site.
By Katrin Leadley, MD
A review of the current clinical trial data.
By Alaide Chieffo, MD, and Valeria Magni, MD
How intravascular ultrasound and fractional flow reserve can be used in this challenging subset.
By Juzar Lokhandwala, MD, and John McB Hodgson, MD, FACC, FSCAI
How the SYNTAX data look from the other side.
By David Taggart, MD
A review of the guidelines and appropriate use criteria.
By Manesh R. Patel, MD; Gregory J. Dehmer, MD; and Ralph G. Brindis, MD, MPH
Critical elements you should consider to help ensure that your agreement suits your specific needs.
By Terrell J. Isselhard, JD
Pediatric cardiologist Zahid Amin, MD, discusses animal research and robotic assistance, as well as what he believes shows promise for percutaneous valve repair and structural heart disease treatments.